Patient value has now become synonymous with business value. Companies listening to the growing patient voice and incorporating those insights into the design of products, trials and strategy are being rewarded with higher uptake and better outcomes. Patients are no longer just recipients of care, they are also active partners in the design and masters of their own care decisions.
Fortunately for pharma, it’s never been easier to speak to patients. Digital avenues, social media engaged advocacy groups and, most importantly, a receptive audience means pharma has the opportunity and the technology to interact with patients and build what they want.
Opportunities are aplenty for those willing to walk the talk on patient engagement. Are you a walker or a talker?
Speakers: Erik Janssen, Vice President Patient Relevant Innovative Solutions Mission Neurology, UCB, Jan Nissen, Vice President Patient Innovation and Engagement, Merck, Mohanad Fors, Global Head Digital Innovation Lab, Novartis, Camilla Krogh Lauritzen, Chief Patient Officer, Rare Diseases, LEO Pharma, Craig Lipset, Head of Clinical Innovation, Pfizer, Michelle Rice, Senior Vice President External Affairs, National Hemophilia Foundation, TJ Sharpe, Patient Advocate
Time: 8:30 am to 3:30 pm
Passes from: GBP 1799.0
Find Bestrade reviews helpful? Start helping others by sharing your own experience:
eyeforpharma Patient Summit USA
Reviews are public and modifiable.
|Twice a year or more|